Privi Speciality Chemicals FY26 Net Profit Up 89%

Board approved audited standalone and consolidated financial results for Q4 and FY ended March 31, 2026, reporting significant YoY growth in revenue and profit.
Recommended a final dividend of ₹10 (100%) per equity share, subject to shareholder approval at the 41st AGM.
Re-appointed Mr. Bhaktavatsala Rao Doppalapudi as Executive Director and reappointed internal and cost auditors for FY27.
The statutory auditors issued an unmodified opinion on both the standalone and consolidated financial results.